HK Stock MarketDetailed Quotes
01518 NC HEALTHCARE
- 1.000
- +0.030+3.09%
Not Open Dec 12 16:08 CST
490.03MMarket Cap5.18P/E (TTM)
0.000High0.000Low0Volume1.000Open0.970Pre Close0.00Turnover0.00%Turnover Ratio5.26P/E (Static)490.03MShares1.25052wk High0.84P/B490.03MFloat Cap0.61252wk Low0.04Dividend TTM490.03MShs Float22.912Historical High0.038Dividend LFY0.00%Amplitude0.322Historical Low--Avg Price500Lot Size3.80%Div YieldTTM3.80%Div Yield LFY
NC HEALTHCARE Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -0.04%415.96M | 46.60%933.07M | 48.56%416.13M | 0.62%636.46M | -2.01%280.1M | 23.36%632.57M | 31.91%285.84M | -29.69%512.79M | -36.73%216.69M | 18.41%729.37M |
| Operating income | -0.04%415.96M | 46.60%933.07M | 48.56%416.13M | 0.62%636.46M | -2.01%280.1M | 23.36%632.57M | 31.91%285.84M | -29.69%512.79M | -36.73%216.69M | 18.41%729.37M |
| Cost of sales | -0.37%-247.24M | -21.11%-525.99M | -15.40%-246.34M | -0.11%-434.32M | -1.36%-213.46M | -15.07%-433.83M | -20.78%-210.6M | 19.45%-377.02M | 21.95%-174.36M | -23.69%-468.07M |
| Operating expenses | -0.37%-247.24M | -21.11%-525.99M | -15.40%-246.34M | -0.11%-434.32M | -1.36%-213.46M | -15.07%-433.83M | -20.78%-210.6M | 19.45%-377.02M | 21.95%-174.36M | -23.69%-468.07M |
| Gross profit | -0.63%168.72M | 101.39%407.09M | 154.78%169.8M | 1.71%202.14M | -11.43%66.65M | 46.38%198.74M | 77.76%75.25M | -48.04%135.76M | -64.45%42.33M | 9.99%261.3M |
| Selling expenses | 0.72%-32.76M | -9.60%-68.27M | -1.46%-33M | -2.43%-62.29M | -17.60%-32.53M | -37.99%-60.81M | -38.18%-27.66M | 0.30%-44.07M | -4.61%-20.02M | -44.38%-44.2M |
| Administrative expenses | 4.11%-60.84M | 1.48%-129.88M | 1.66%-63.45M | 15.73%-131.83M | 6.98%-64.52M | -26.90%-156.43M | -21.38%-69.37M | 15.87%-123.27M | 17.51%-57.15M | -28.00%-146.52M |
| Research and development expenses | 27.48%-2.23M | 22.94%-5.93M | 27.57%-3.07M | 27.23%-7.7M | 28.70%-4.24M | 26.91%-10.57M | -10.15%-5.95M | -277.63%-14.47M | ---5.4M | ---3.83M |
| Impairment and provision | 86.13%-873K | 88.51%-32.43M | 96.82%-6.29M | -1,149.74%-282.34M | -2,571.85%-198.2M | 91.65%-22.59M | 97.05%-7.42M | -255,071.70%-270.48M | ---251.46M | ---106K |
| -Other impairment is provision | 86.13%-873K | 88.51%-32.43M | 96.82%-6.29M | -1,149.74%-282.34M | -2,571.85%-198.2M | 91.65%-22.59M | 97.05%-7.42M | -255,071.70%-270.48M | ---251.46M | ---106K |
| Special items of operating profit | -38.85%351K | -63.27%1.23M | 1.95%574K | -50.74%3.36M | -88.11%563K | -12.11%6.82M | -41.27%4.73M | 293.11%7.76M | 316.97%8.06M | -190.97%-4.02M |
| Operating profit | 12.10%72.36M | 161.66%171.81M | 127.79%64.55M | -521.29%-278.65M | -663.85%-232.28M | 85.47%-44.85M | 89.28%-30.41M | -593.03%-308.76M | -969.88%-283.63M | -35.38%62.63M |
| Financing income | -25.17%2.78M | -69.77%2.94M | -31.88%3.72M | 217.65%9.72M | 199.07%5.46M | -6.94%3.06M | -53.55%1.83M | -24.54%3.29M | 468.60%3.93M | -80.52%4.36M |
| Financing cost | 8.26%-4.25M | 34.60%-8.52M | 29.69%-4.64M | 21.73%-13.03M | 24.37%-6.59M | 28.61%-16.65M | -11.16%-8.72M | -23.76%-23.33M | 25.01%-7.84M | ---18.85M |
| Share of profits of associates | ---- | ---- | ---- | ---- | ---211K | ---- | ---- | ---- | ---- | ---- |
| Special items of earning before tax | 937.40%1.28M | 98.99%-80K | --123K | -1,021.91%-7.89M | ---- | -1,401.85%-703K | ---557K | 180.60%54K | ---- | ---67K |
| Earning before tax | 13.19%72.17M | 157.32%166.14M | 127.29%63.76M | -390.06%-289.85M | -517.12%-233.63M | 82.01%-59.15M | 86.83%-37.86M | -783.96%-328.75M | -1,358.90%-287.55M | -59.70%48.07M |
| Tax | -21.55%-23.86M | -1,879.83%-34.05M | -1,659.05%-19.63M | 93.41%-1.72M | 90.11%-1.12M | 46.47%-26.12M | 64.43%-11.28M | -11.97%-48.79M | -68.44%-31.73M | 4.94%-43.57M |
| After-tax profit from continuing operations | 9.48%48.31M | 145.30%132.09M | 118.80%44.13M | -241.97%-291.57M | -377.69%-234.74M | 77.42%-85.26M | 84.61%-49.14M | -8,502.72%-377.53M | -8,069.80%-319.27M | -93.88%4.49M |
| Earning after tax | 9.48%48.31M | 145.30%132.09M | 118.80%44.13M | -241.97%-291.57M | -377.69%-234.74M | 77.42%-85.26M | 84.61%-49.14M | -8,502.72%-377.53M | -8,069.80%-319.27M | -93.88%4.49M |
| Minority profit | 9.93%23.11M | 677.88%47.93M | 2,023.79%21.03M | -61.97%6.16M | -120.56%-1.09M | 363.36%16.2M | 147.32%5.32M | -119.81%-6.15M | -183.85%-11.23M | -2.74%31.05M |
| Profit attributable to shareholders | 9.07%25.19M | 128.27%84.16M | 109.89%23.1M | -193.45%-297.73M | -329.05%-233.65M | 72.68%-101.46M | 82.32%-54.46M | -1,298.49%-371.38M | -3,179.77%-308.04M | -163.97%-26.56M |
| Basic earnings per share | 0.00%0.05 | 127.42%0.17 | 110.42%0.05 | -195.24%-0.62 | -336.36%-0.48 | 72.73%-0.21 | 82.54%-0.11 | -1,440.00%-0.77 | -3,050.00%-0.63 | -155.56%-0.05 |
| Diluted earnings per share | 0.00%0.05 | 127.42%0.17 | 110.42%0.05 | -195.24%-0.62 | -336.36%-0.48 | 72.73%-0.21 | 82.54%-0.11 | -1,440.00%-0.77 | -3,050.00%-0.63 | -155.56%-0.05 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
HK
Overall
Symbol
Price
% Chg
No Data